114 related articles for article (PubMed ID: 34982424)
1. LINC00261 regulates EBF1 to suppress malignant progression of thyroid cancer.
Fu XD; Liu CY; Liu YL; Su DW; Chi NN; Zhang JL; Wei WW
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7626-7634. PubMed ID: 34982424
[TBL] [Abstract][Full Text] [Related]
2. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
[TBL] [Abstract][Full Text] [Related]
4. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
[TBL] [Abstract][Full Text] [Related]
5. Circ_0000144 facilitates the progression of thyroid cancer via the miR-217/AKT3 pathway.
Fan YX; Shi HY; Hu YL; Jin XL
J Gene Med; 2020 Dec; 22(12):e3269. PubMed ID: 32890417
[TBL] [Abstract][Full Text] [Related]
6. [Expression of long noncoding RNA linc00261 in hepatocellular carcinoma and its association with postoperative outcomes].
Chen Z; Xiang L; Huang Y; Fang Y; Li X; Yang D
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1179-1186. PubMed ID: 30377132
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of LINC00261 upregulation on the pancreatic cancer EMT process is mediated by KLF13 via the mTOR signaling pathway.
Li B; Pang S; Dou J; Zhou C; Shen B; Zhou Y
Clin Transl Oncol; 2022 Jun; 24(6):1059-1072. PubMed ID: 35066757
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of long noncoding RNA DLX6-AS1 inhibits migration and invasion of thyroid cancer cells by upregulating UPF1.
Zhong ZB; Wu YJ; Luo JN; Hu XN; Yuan ZN; Li G; Wang YW; Yao GD; Ge XF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10867-10873. PubMed ID: 31858555
[TBL] [Abstract][Full Text] [Related]
10. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
11. Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/FOXO3 axis.
Chen T; Lei S; Zeng Z; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
Oncol Rep; 2020 Mar; 43(3):930-942. PubMed ID: 32020223
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-198 inhibits metastasis of thyroid cancer by targeting H3F3A.
Fang J; Zhu JM; Dai HL; He LM; Kong L
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12232-12240. PubMed ID: 33336742
[TBL] [Abstract][Full Text] [Related]
14. Linc00261 suppresses growth and metastasis of non-small cell lung cancer via repressing epithelial-mesenchymal transition.
Liao J; Dong LP
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3829-3837. PubMed ID: 31115010
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of long intergenic noncoding RNA LINC00312 inhibits the invasion and migration of thyroid cancer cells by down-regulating microRNA-197-3p.
Liu K; Huang W; Yan DQ; Luo Q; Min X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28539331
[TBL] [Abstract][Full Text] [Related]
17. LncRNA LINC00261 overexpression suppresses the growth and metastasis of lung cancer via regulating miR-1269a/FOXO1 axis.
Guo C; Shi H; Shang Y; Zhang Y; Cui J; Yu H
Cancer Cell Int; 2020; 20():275. PubMed ID: 32607060
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
[TBL] [Abstract][Full Text] [Related]
19. Expression and Clinical Significance of Long-chain Noncoding RNA LINC00261 in Colon Cancer.
Zhou Z; Ma J
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850713
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
Luo X; Song Y; Tang L; Sun DH; Ji DG
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
